Tetragon Partners GP Ltd 13F holdings
Tetragon Partners GP Ltd reported 32 positions with a total reported value of $614.3M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-13. Top holdings by reported value: PATH UIPATH INC (54.8%), KGEI KOLIBRI GLOBAL ENERGY INC (5.5%), AUTL AUTOLUS THERAPEUTICS LTD (2.5%), LYFT LYFT INC (2.4%), DFTX DEFINIUM THERAPEUTICS INC (2.2%). Against 2026-03-31 it opened 5 new positions and exited 7. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Tetragon Partners GP Ltd files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 32 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| PATH UIPATH INC | 30,950,000 | $336.4M | 54.8% |
| KGEI KOLIBRI GLOBAL ENERGY INC | 6,834,504 | $33.8M | 5.5% |
| AUTL AUTOLUS THERAPEUTICS LTD | 9,500,000 | $15.2M | 2.5% |
| LYFT LYFT INC | 1,000,000 | $14.6M | 2.4% |
| DFTX DEFINIUM THERAPEUTICS INC | 286,990 | $13.5M | 2.2% |
| WK WORKIVA INC | 250,000 | $12.1M | 2.0% |
| CXM SPRINKLR INC | 2,200,000 | $11.4M | 1.8% |
| MBX MBX BIOSCIENCES INC | 203,543 | $11.2M | 1.8% |
| ALKT ALKAMI TECHNOLOGY INC | 600,284 | $10.9M | 1.8% |
| CLDX CELLDEX THERAPEUTICS INC NEW | 290,441 | $10.8M | 1.8% |
| RLAY RELAY THERAPEUTICS INC | 570,311 | $10.7M | 1.7% |
| ARWR ARROWHEAD PHARMACEUTICALS IN | 130,484 | $10.6M | 1.7% |
| PHVS PHARVARIS N V | 295,627 | $10.2M | 1.7% |
| ALKS ALKERMES PLC | 189,979 | $10.0M | 1.6% |
| IMVT IMMUNOVANT INC | 255,934 | $9.9M | 1.6% |
| SLN SILENCE THERAPEUTICS PLC | 764,256 | $8.4M | 1.4% |
| DYN DYNE THERAPEUTICS INC | 356,657 | $7.9M | 1.3% |
| IONS IONIS PHARMACEUTICALS INC | 97,173 | $7.7M | 1.3% |
| AGIO AGIOS PHARMACEUTICALS INC | 205,579 | $7.6M | 1.2% |
| HRMY HARMONY BIOSCIENCES HLDGS IN | 201,036 | $7.3M | 1.2% |
| KRYS KRYSTAL BIOTECH INC | 19,668 | $7.3M | 1.2% |
| ANNX ANNEXON INC | 1,242,455 | $7.1M | 1.2% |
| CELC CELCUITY INC | 64,110 | $6.7M | 1.1% |
| WBD WARNER BROS DISCOVERY INC | 250,000 | $6.7M | 1.1% |
| NKTR NEKTAR THERAPEUTICS | 86,996 | $6.1M | 1.0% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 5 in all · reported value as of 2026-06-30
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 7 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| PRAX PRAXIS PRECISION MEDICINES I | 15,952 | $5.1M | 1.0% |
| SOLENO THERAPEUTICS INC | 102,125 | $3.4M | 0.7% |
| AXSM AXSOME THERAPEUTICS INC. | 20,059 | $3.4M | 0.7% |
| MPLT MAPLIGHT THERAPEUTICS INC | 112,115 | $2.3M | 0.4% |
| AARD AARDVARK THERAPEUTICS INC | 316,621 | $1.2M | 0.2% |
| RARE ULTRAGENYX PHARMACEUTICAL IN | 39,473 | $827.0K | 0.2% |
| KPTI KARYOPHARM THERAPEUTICS INC | 52,984 | $295.1K | <0.1% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| PATH UIPATH INC | 25,207,628 | 30,950,000 | +22.8% | $336.4M |
| RLAY RELAY THERAPEUTICS INC | 181,543 | 570,311 | +214.1% | $10.7M |
| IONS IONIS PHARMACEUTICALS INC | 41,764 | 97,173 | +132.7% | $7.7M |
| DFTX DEFINIUM THERAPEUTICS INC | 199,994 | 286,990 | +43.5% | $13.5M |
| MBX MBX BIOSCIENCES INC | 145,480 | 203,543 | +39.9% | $11.2M |
| HRMY HARMONY BIOSCIENCES HLDGS IN | 119,340 | 201,036 | +68.5% | $7.3M |
| PHVS PHARVARIS N V | 221,611 | 295,627 | +33.4% | $10.2M |
| DYN DYNE THERAPEUTICS INC | 258,132 | 356,657 | +38.2% | $7.9M |
| ALKS ALKERMES PLC | 159,791 | 189,979 | +18.9% | $10.0M |
| AGIO AGIOS PHARMACEUTICALS INC | 164,839 | 205,579 | +24.7% | $7.6M |
| SLN SILENCE THERAPEUTICS PLC | 630,161 | 764,256 | +21.3% | $8.4M |
| IMVT IMMUNOVANT INC | 218,507 | 255,934 | +17.1% | $9.9M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| WBD WARNER BROS DISCOVERY INC | 923,725 | 250,000 | -72.9% | $6.7M |
| NKTR NEKTAR THERAPEUTICS | 103,037 | 86,996 | -15.6% | $6.1M |
| CLDX CELLDEX THERAPEUTICS INC NEW | 312,316 | 290,441 | -7.0% | $10.8M |
| AMLX AMYLYX PHARMACEUTICALS INC | 317,877 | 297,926 | -6.3% | $5.4M |
| ANNX ANNEXON INC | 1,292,455 | 1,242,455 | -3.9% | $7.1M |
CIK 1515070 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
